A recent study has demonstrated that a precision medicine approach improves treatment selection for patients with soft tissue ...

Natera has announced findings from a study evaluating its personalised tumour-informed molecular residual disease (MRD) test, ...

A phase 2 study showed that giving maintenance regorafenib could delay disease progression in patients with non-adipocytic ...

Soft tissue sarcoma is a type of cancerous tumor that forms in the body’s soft tissues, such as muscle, fat, fibrous tissue, and blood vessels. If it occurs in the shoulder, it might feel like a ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced the results of a study ...

A study conducted by researchers from the Agency for Science, Technology and Research (A*STAR), National Cancer Centre Singapore (NCCS ...

The following is a summary of "Impact of CT-based adipose tissue distribution and sarcopenia on treatment outcomes in ...

In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...

India got the first of its kind advanced cancer treatment system that tracks cancer tumors in real time. Known as Elekta ...

Not much is known about this difficult disease sarcoma cancer because it is easy to ignore the small lumps in the beginning ...

Multicenter study sponsored by SELNET to evaluate cirtuvivint as a second-line monotherapy in selected sarcoma subtypes. SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Biosplice Ther ...